http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20060002-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436
filingDate 2005-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6e0519d6d6820f578fffcf69e037614
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caebf44a07db405f683e6d8fe45f7404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85f7092122eafed309bc6fa7ff4c86f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_006f43bf1eea1e6200dfcb76cd90b579
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a27ca279b82b2aa58765f2556589e9eb
publicationDate 2006-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20060002-A1
titleOfInvention ANTINEOPLASTIC COMBINATIONS OF CCI-779 AND RITUXIMAB
abstract IT REFERS TO A COMPOSITION OF TEMSIRULIMUS (CCI-779) WITH INITIAL DOSES BETWEEN 25-175 mg ADMINISTERED PREFERENTIALLY BY ORAL ROUTE AND RITUXIMAB IN SINGLE DOSES BY INTRAVENOUS ROUTE IN CONCENTRATIONS OF 10-500 mg / m2. SUCH COMPOSITION, ADMINISTERED IN SUBTERAPEUTICALLY EFFECTIVE QUANTITIES, REDUCES THE COLLATERAL EFFECTS OF TREATMENT WITH RITUXIMAB. IT ALSO REFERS TO A UNIT DOSAGE PHARMACEUTICAL COMPOSITION BEING USEFUL IN THE TREATMENT OF NON-HODGKIN LYMPHOMA
priorityDate 2004-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918289

Total number of triples: 26.